February 5, 2021, the State Food and Drug Administration issued a notice, Jiangsu Tasly Diyi Pharmaceutical Co., LTD clozapine tablets successfully approved! The clinical study of this variety is undertaken by Duzheng Biology (Duzheng Biological Analysis and Testing Center provides biological analysis and testing services, and farmar Ke data performs data management and statistical analysis). The inspection, which analysis testing units are exempt from inspection, fully affirmed the state food and Drug Administration is biological accreditation.

Clozapine tablet, indications for this product is not only effective on positive symptoms of mental illness, negative symptoms also have a certain effect. It is suitable for all subtypes of acute and chronic schizophrenia, and has good effect on hallucinations and delusions. It may also reduce the emotional symptoms associated with schizophrenia (e.g., depression, guilt, anxiety). In some patients who do not respond to conventional antipsychotics or who do not respond to conventional antipsychotics, this product may be effective. It is also used to treat hypomania or other psychotic disorders of agitation and delusions. 

---

Duzheng Biology provides "one-stop" service for drug clinical research, and has helped many pharmaceutical companies successfully obtain approval! 

In the future, the company will continue to uphold the enterprise purpose of "innovation and truth-seeking", with the service concept of "customer as the center", and help the development of China's pharmaceutical industry!